Milestone Scientific, Inc. (MLSS)

NYSEAMERICAN: MLSS · IEX Real-Time Price · USD
1.25
-0.01 (-0.79%)
Jan 28, 2022 2:53 PM EST - Market open
Market Cap84.81M
Revenue (ttm)9.67M
Net Income (ttm)-6.78M
Shares Out67.85M
EPS (ttm)-0.10
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume160,174
Open1.26
Previous Close1.26
Day's Range1.16 - 1.26
52-Week Range1.16 - 4.85
Beta1.15
AnalystsBuy
Price Target6.00 (+380.0%)
Earnings Daten/a

About MLSS

Milestone Scientific, Inc. develops computer-controlled anesthetic delivery devices for the medical and dental markets in the United States, China, and internationally. The company operates in two segments, Dental and Medical. Its products include CompuDent System that are used to control the flow rate of the anesthesia during the injection, which allows virtually painless injections for various dental procedures, including routine fillings, implants, root canals, and crowns. The company also offers CompuFlo, a computer-controlled drug delivery...

IndustryHealth Care Equipment & Supplies
IPO DateNov 3, 1995
Employees19
Stock ExchangeNYSEAMERICAN
Ticker SymbolMLSS
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 2 analysts, the average rating for MLSS stock is "Buy." The 12-month stock price forecast is 6.00, which is an increase of 380.00% from the latest price.

Price Target
$6.00
(380.00% upside)
Analyst Consensus: Buy

News

Milestone Scientific CEO to Participate in Fireside Chat Hosted by Maxim Group and M-Vest on January 20th

ROSELAND, N.J., Jan. 18, 2022 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide virtually painless and precise inject...

1 week ago - GlobeNewsWire

Milestone Scientific Projects Revenue to Increase Over 85% to More than $10 Million for 2021

ROSELAND, N.J., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide virtually painless and precise inject...

2 weeks ago - GlobeNewsWire

Milestone Scientific to Present at the H.C. Wainwright BioConnect 2022 Conference

ROSELAND, N.J., Jan. 07, 2022 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today...

3 weeks ago - GlobeNewsWire

Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within Prominent Pain Clinic with Leading Phys...

Reports continued expansion into pain management market following successful evaluation by Dr. Harsh Govil, MD, MPH Reports continued expansion into pain management market following successful evaluatio...

3 weeks ago - GlobeNewsWire

Milestone Scientific Announces Purchase of CompuFlo / CathCheck™ Verification System Disposables at Two Additional Pr...

Both hospitals belong to large hospital systems representing future growth opportunities Both hospitals belong to large hospital systems representing future growth opportunities

1 month ago - GlobeNewsWire

Milestone Scientific Names Andau Medical as an Additional Distributor for the STA Single Tooth Anesthesia System® in ...

ROSELAND, N.J., Dec. 23, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, toda...

1 month ago - GlobeNewsWire

Milestone Scientific Announces Purchase Agreement for its CompuFlo® Epidural / CathCheck™ Verification System Disposa...

ROSELAND, N,J., Dec. 22, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, toda...

1 month ago - GlobeNewsWire

Milestone Scientific CEO Arjan Haverhals to Participate in the Benzinga All Access Event on December 16th

Mr. Haverhals to provide update on growing sales pipeline and goals for 2022 Mr. Haverhals to provide update on growing sales pipeline and goals for 2022

1 month ago - GlobeNewsWire

Dr. Miguel de la Garza, President of the Florida Society of Interventional Pain Physicians and Renowned Physician at ...

Marks important step in planned expansion of the CompuFlo Epidural instrument into the pain management market Marks important step in planned expansion of the CompuFlo Epidural instrument into the pain ...

1 month ago - GlobeNewsWire

Milestone Scientific, Inc. (MLSS) Reports Q3 Loss, Lags Revenue Estimates

Milestone Scientific, Inc. (MLSS) delivered earnings and revenue surprises of -50.00% and -6.31%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the...

2 months ago - Zacks Investment Research

Milestone Scientific: Q3 Earnings Insights

Milestone Scientific (AMEX:MLSS) reported its Q3 earnings results on Monday, November 15, 2021 at 08:00 AM. Here's what investors need to know about the announcement.

2 months ago - Benzinga

Milestone Scientific Reports 69% Increase in Revenue for Third Quarter of 2021

ROSELAND, N.J., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc . (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, toda...

2 months ago - GlobeNewsWire

Milestone Scientific Schedules Third Quarter 2021 Business Update Conference Call

ROSELAND, N.J., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, toda...

2 months ago - GlobeNewsWire

Milestone Scientific, Inc. (MLSS) May Report Negative Earnings: Know the Trend Ahead of Q3 Release

Milestone Scientific, Inc. (MLSS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 months ago - Zacks Investment Research

Milestone Scientific to Present at Dawson James Securities 6th Annual Small Cap Growth Conference on October 21, 2021

ROSELAND, N.J., Oct. 18, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today...

3 months ago - GlobeNewsWire

Milestone Scientific Announces International Expansion for their CompuFlo® Epidural Instrument

Signs distributors in Canada, Slovenia and United Arab Emirates; expands commercial usage at leading hospital in Germany Signs distributors in Canada, Slovenia and United Arab Emirates; expands commerci...

3 months ago - GlobeNewsWire

Milestone Scientific to Present at Microcap Rodeo's Fall Harvest - Best Ideas from the Buy-Side on Wednesday, October...

ROSELAND, NJ / ACCESSWIRE / October 5, 2021 / Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today an...

3 months ago - Accesswire

Milestone Scientific Approved as Vendor to Supply CompuFlo® Epidural/ CathCheck™ Verification System Across Florida's...

ROSELAND, N.J., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, toda...

3 months ago - GlobeNewsWire

Milestone Scientific, Inc. (MLSS) Reports Q2 Loss, Tops Revenue Estimates

Milestone Scientific, Inc. (MLSS) delivered earnings and revenue surprises of -100.00% and 7.82%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

5 months ago - Zacks Investment Research

Milestone Scientific Reports Fourteen-Fold Increase in Revenue for Second Quarter of 2021

ROSELAND, N.J., Aug. 16, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc . (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, toda...

5 months ago - GlobeNewsWire

Milestone Scientific Schedules Second Quarter 2021 Business Update Conference Call

ROSELAND, N.J., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American: MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and prec...

5 months ago - GlobeNewsWire

Milestone Scientific, Inc. (MLSS) May Report Negative Earnings: Know the Trend Ahead of Q2 Release

Milestone Scientific, Inc. (MLSS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

5 months ago - Zacks Investment Research

Milestone Scientific Commences Sales of CompuFlo® / CathCheck™ Disposables within the UTMB Health Clear Lake Campus H...

Agreement represents second hospital within the UTMB Health network Agreement represents second hospital within the UTMB Health network

6 months ago - GlobeNewsWire

Implied Volatility Surging for Milestone Scientific (MLSS) Stock Options

Investors need to pay close attention to Milestone Scientific (MLSS) stock based on the movements in the options market lately.

7 months ago - Zacks Investment Research

Milestone Scientific, Inc. (MLSS) Moves to Buy: Rationale Behind the Upgrade

Milestone Scientific, Inc. (MLSS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

7 months ago - Zacks Investment Research